ATE451458T1 - Verfahren zur beurteilung des verkrebsungsgrades - Google Patents

Verfahren zur beurteilung des verkrebsungsgrades

Info

Publication number
ATE451458T1
ATE451458T1 AT04773354T AT04773354T ATE451458T1 AT E451458 T1 ATE451458 T1 AT E451458T1 AT 04773354 T AT04773354 T AT 04773354T AT 04773354 T AT04773354 T AT 04773354T AT E451458 T1 ATE451458 T1 AT E451458T1
Authority
AT
Austria
Prior art keywords
assessing
cancer
degree
mammal
index value
Prior art date
Application number
AT04773354T
Other languages
English (en)
Inventor
Toshikazu Ushijima
Atsushi Hagihara
Original Assignee
Sumitomo Chemical Co
Japan Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co, Japan Government filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of ATE451458T1 publication Critical patent/ATE451458T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04773354T 2003-09-16 2004-09-15 Verfahren zur beurteilung des verkrebsungsgrades ATE451458T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003322822A JP5116936B2 (ja) 2003-09-16 2003-09-16 哺乳動物由来の検体の癌化度を評価する方法
PCT/JP2004/013871 WO2005026350A1 (ja) 2003-09-16 2004-09-15 癌化度評価方法

Publications (1)

Publication Number Publication Date
ATE451458T1 true ATE451458T1 (de) 2009-12-15

Family

ID=34308682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04773354T ATE451458T1 (de) 2003-09-16 2004-09-15 Verfahren zur beurteilung des verkrebsungsgrades

Country Status (7)

Country Link
US (1) US7763422B2 (de)
EP (1) EP1679370B1 (de)
JP (1) JP5116936B2 (de)
AT (1) ATE451458T1 (de)
DE (1) DE602004024569D1 (de)
ES (1) ES2336451T3 (de)
WO (1) WO2005026350A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008136404A (ja) * 2006-11-30 2008-06-19 Sysmex Corp Dnaメチル化検出における非メチル化シトシン変換処理後のdna量の確認方法
US20140127691A1 (en) 2011-06-29 2014-05-08 Kagoshima University Method for diagnosing type of pancreatic tumor
EP2840065B1 (de) 2013-08-20 2016-11-16 Omya International AG Verfahren zum erhalt von fällungscalciumcarbonat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478510A1 (en) 2002-03-07 2003-09-18 The Johns Hopkins University Genomic screen for epigenetically silenced tumor suppressor genes

Also Published As

Publication number Publication date
JP5116936B2 (ja) 2013-01-09
EP1679370A4 (de) 2006-11-22
JP2005087046A (ja) 2005-04-07
ES2336451T3 (es) 2010-04-13
WO2005026350A1 (ja) 2005-03-24
US20070135366A1 (en) 2007-06-14
EP1679370A1 (de) 2006-07-12
EP1679370B1 (de) 2009-12-09
DE602004024569D1 (de) 2010-01-21
US7763422B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
WO2010006048A3 (en) Gene expression profiling for predicting the survivability of prostate cancer subjects
IL252832A0 (en) Use of biomarkers for detecting ovarian cancer
WO2008069881A3 (en) Gene expression profiling for identification, monitoring and treatment of melanoma
DK1372469T3 (da) Fremgangsmåde til bestemmelse af de optiske egenskaber af et flerlaget væv
ATE520979T1 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE60336239D1 (de) Signalsuchverfahren für ein positionierungssystem
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
EP1415152A4 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE492815T1 (de) Diagnostik-biomolekül(e)
DE602005013998D1 (de) Verfahren und reagenzien zur erkennung von melanomen
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
WO2004077057A8 (en) Standard for immunohistochemistry, immunocytochemistry and molecular cytogenetics
WO2008108873A3 (en) Molecular biosensors for detecting macromolecules and other analytes
ATE553458T1 (de) Verfahren zur unvorbetonten schätzung der gesamtmenge von objekten auf der basis ungleichförmiger stichproben mit durch verwendung von bildanalyse erhaltener wahrscheinlichkeit
ATE342500T1 (de) Verfahren zur erkennung und kompensation der unterdosierung von teststreifen
ATE525637T1 (de) Verfahren zur messung der trübung eines films
ATE451458T1 (de) Verfahren zur beurteilung des verkrebsungsgrades
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties